Video

Oncology
Henar Hevia and Carolyn Sousa at ASCO 2024

ASCO 2024 - Henar Hevia and Carolyn Sousa

The future of cancer care is personalisation. New breakthroughs are increasingly highly targeted, with powerful results, but only for patients with particular genetic markers.

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

Oncology
ASCO Mohit Manrao feature

ASCO 2024 - Mohit Manrao

Just about everyone seems to agree that the runaway success story of ASCO this year is AstraZeneca, with plenary sessions for the sixth year in a row and

Oncology
CAR-TCR 2023 – Jonathan Wofford

CAR-TCR 2023 – Jonathan Wofford

In order for cell therapies to scale effectively, the industry is clamouring for standardisation around things like manufacturing and treatment administration.

Oncology
CAR-TCR 2023 – Mindy Miller

CAR-TCR 2023 – Mindy Miller

As more cell therapies are approved and the category emerges, there’s also an increased need for the technology that enables cell therapy development.

Oncology
CAR-TCR 2023 – Matt Lakelin

CAR-TCR 2023 – Matt Lakelin

Innovative, advanced therapies have enormous promise, but also come with a host of logistical problems that innovators underestimate at their own peril.